A detailed history of Sentinus, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sentinus, LLC holds 5,019 shares of EW stock, worth $379,687. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,019
Previous 5,007 0.24%
Holding current value
$379,687
Previous $462,000 28.35%
% of portfolio
0.08%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $716 - $1,125
12 Added 0.24%
5,019 $331,000
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $6,659 - $7,450
79 Added 1.6%
5,007 $462,000
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $17,772 - $23,412
-245 Reduced 4.74%
4,928 $470,000
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $4,558 - $5,282
-56 Reduced 1.07%
5,173 $487,000
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $388,305 - $441,902
5,229 New
5,229 $432,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Sentinus, LLC Portfolio

Follow Sentinus, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinus, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentinus, LLC with notifications on news.